Joseph E Aslan Selected Research

Vascular System Injuries

4/2017

Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph E Aslan Research Topics

Disease

12	Thrombosis (Thrombus) 02/2024 - 11/2010
5	Inflammation (Inflammations) 01/2024 - 11/2020
4	Iron Deficiencies 02/2023 - 02/2022
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2023
2	Hemorrhage 02/2024 - 03/2016
2	Iron Overload 02/2023 - 01/2023
2	Atherosclerosis 01/2023 - 06/2022
2	Neoplasms (Cancer) 01/2012 - 09/2011
1	Thromboinflammation 01/2024
1	Stroke (Strokes) 10/2023
1	Constipation 02/2023
1	Dyspepsia (Indigestion) 02/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Fatigue 01/2023
1	Hyperlipidemias (Hyperlipidemia) 01/2023
1	Insulin Resistance 01/2023
1	Obesity 01/2023
1	Crohn Disease (Crohn's Disease) 10/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022
1	Hematologic Neoplasms (Hematological Malignancy) 10/2022
1	Anemia 02/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Pain (Aches) 01/2022
1	Chronic Pain 01/2022
1	Sepsis (Septicemia) 05/2020
1	Pneumonia (Pneumonitis) 05/2020
1	COVID-19 05/2020
1	Body Weight (Weight, Body) 01/2020
1	Vascular System Injuries 04/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2016
1	Bruton type agammaglobulinemia 03/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2010
1	Multiple Sclerosis 11/2010
1	Cholestasis 01/2006

Drug/Important Bio-Agent (IBA)

5	Hemostatics (Antihemorrhagics)IBA 10/2022 - 01/2012
4	IronIBA 02/2023 - 02/2022
3	Blood Coagulation Factors (Coagulation Factor)IBA 02/2024 - 05/2020
3	ibrutinibIBA 01/2023 - 03/2016
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2020
3	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2019 - 01/2012
2	CytokinesIBA 01/2022 - 05/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2016
2	CollagenIBA 01/2019 - 11/2010
1	Monoclonal AntibodiesIBA 02/2024
1	nitinolIBA 02/2024
1	Blocking AntibodiesIBA 02/2024
1	Thrombin FDA Link 01/2024
1	ProteomeIBA 10/2023
1	metal transporting protein 1 (ferroportin)IBA 02/2023
1	HepcidinsIBA 02/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	Saline SolutionIBA 01/2023
1	TicagrelorIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023
1	FlavonoidsIBA 10/2022
1	xanthohumolIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 10/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	EndocannabinoidsIBA 01/2022
1	Medical MarijuanaIBA 01/2022
1	ActomyosinIBA 09/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021
1	GTP Phosphohydrolases (GTPases)IBA 09/2021
1	Tamoxifen FDA LinkGeneric 01/2020
1	Adenosine Diphosphate (ADP)IBA 06/2018
1	platelet membrane glycoprotein VIIBA 03/2016
1	Phospholipases (Phospholipase)IBA 03/2016
1	bcr-abl Fusion ProteinsIBA 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2015
1	Chemokine ReceptorsIBA 09/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2010
1	Peptides (Polypeptides)IBA 11/2010
1	SolutionsIBA 11/2010
1	LigandsIBA 11/2010
1	fas Receptor (CD95 Antigen)IBA 01/2006

Therapy/Procedure

3	Therapeutics 02/2024 - 10/2022
2	Stents 02/2024 - 01/2012
1	Length of Stay 01/2023
1	Resuscitation 01/2023
1	Immunotherapy 01/2012